SK127699A3 - 2,3-dihydrofuro[3,2-b]pyridin, preparation and application thereof in therapy - Google Patents
2,3-dihydrofuro[3,2-b]pyridin, preparation and application thereof in therapy Download PDFInfo
- Publication number
- SK127699A3 SK127699A3 SK1276-99A SK127699A SK127699A3 SK 127699 A3 SK127699 A3 SK 127699A3 SK 127699 A SK127699 A SK 127699A SK 127699 A3 SK127699 A3 SK 127699A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- compound
- carbon atoms
- compounds
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9703395A FR2761072B1 (fr) | 1997-03-20 | 1997-03-20 | Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique |
PCT/FR1998/000531 WO1998042713A1 (fr) | 1997-03-20 | 1998-03-17 | DERIVES DE 2,3-DIHYDROFURO[3,2-b]PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
Publications (1)
Publication Number | Publication Date |
---|---|
SK127699A3 true SK127699A3 (en) | 2000-05-16 |
Family
ID=9505006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1276-99A SK127699A3 (en) | 1997-03-20 | 1998-03-17 | 2,3-dihydrofuro[3,2-b]pyridin, preparation and application thereof in therapy |
Country Status (22)
Country | Link |
---|---|
US (1) | US6143761A (zh) |
EP (1) | EP0971929A1 (zh) |
JP (1) | JP2001518099A (zh) |
KR (1) | KR20000076282A (zh) |
CN (1) | CN1251105A (zh) |
AR (1) | AR012097A1 (zh) |
AU (1) | AU6924298A (zh) |
BG (1) | BG103684A (zh) |
BR (1) | BR9808346A (zh) |
CA (1) | CA2282320A1 (zh) |
CO (1) | CO4940417A1 (zh) |
EE (1) | EE9900414A (zh) |
FR (1) | FR2761072B1 (zh) |
HU (1) | HUP0002335A3 (zh) |
IL (1) | IL131254A0 (zh) |
NO (1) | NO994527L (zh) |
NZ (1) | NZ337566A (zh) |
PL (1) | PL335759A1 (zh) |
SK (1) | SK127699A3 (zh) |
TR (1) | TR199902115T2 (zh) |
WO (1) | WO1998042713A1 (zh) |
ZA (1) | ZA982365B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2790474B1 (fr) | 1999-03-05 | 2001-04-06 | Synthelabo | Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique |
SE9902267D0 (sv) * | 1999-06-16 | 1999-06-16 | Astra Ab | New compounds |
JP2005104838A (ja) * | 2003-01-09 | 2005-04-21 | Tanabe Seiyaku Co Ltd | 縮合フラン化合物 |
JP5254616B2 (ja) | 2004-09-13 | 2013-08-07 | クロノ セラピューティクス、インコーポレイテッド | 生物学的同調性(biosynchronous)経皮的薬物送達 |
CN103977003A (zh) | 2007-04-02 | 2014-08-13 | 帕金森氏病研究院 | 用于降低治疗的副作用的方法和组合物 |
JP2018511355A (ja) | 2015-01-28 | 2018-04-26 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 薬剤送達方法及びシステム |
US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
US11285306B2 (en) | 2017-01-06 | 2022-03-29 | Morningside Venture Investments Limited | Transdermal drug delivery devices and methods |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2227695C (en) * | 1995-07-28 | 2008-02-12 | Abbott Laboratories | Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
-
1997
- 1997-03-20 FR FR9703395A patent/FR2761072B1/fr not_active Expired - Fee Related
-
1998
- 1998-03-17 AU AU69242/98A patent/AU6924298A/en not_active Abandoned
- 1998-03-17 CA CA002282320A patent/CA2282320A1/en not_active Abandoned
- 1998-03-17 HU HU0002335A patent/HUP0002335A3/hu unknown
- 1998-03-17 EP EP98914931A patent/EP0971929A1/fr not_active Withdrawn
- 1998-03-17 SK SK1276-99A patent/SK127699A3/sk unknown
- 1998-03-17 EE EEP199900414A patent/EE9900414A/xx unknown
- 1998-03-17 BR BR9808346-5A patent/BR9808346A/pt not_active IP Right Cessation
- 1998-03-17 US US09/381,098 patent/US6143761A/en not_active Expired - Fee Related
- 1998-03-17 JP JP54444598A patent/JP2001518099A/ja active Pending
- 1998-03-17 IL IL13125498A patent/IL131254A0/xx unknown
- 1998-03-17 CN CN98803563A patent/CN1251105A/zh active Pending
- 1998-03-17 PL PL98335759A patent/PL335759A1/xx unknown
- 1998-03-17 KR KR1019997008379A patent/KR20000076282A/ko not_active Application Discontinuation
- 1998-03-17 NZ NZ337566A patent/NZ337566A/xx unknown
- 1998-03-17 WO PCT/FR1998/000531 patent/WO1998042713A1/fr not_active Application Discontinuation
- 1998-03-17 TR TR1999/02115T patent/TR199902115T2/xx unknown
- 1998-03-18 AR ARP980101212A patent/AR012097A1/es unknown
- 1998-03-18 CO CO98015204A patent/CO4940417A1/es unknown
- 1998-03-19 ZA ZA982365A patent/ZA982365B/xx unknown
-
1999
- 1999-08-24 BG BG103684A patent/BG103684A/xx unknown
- 1999-09-17 NO NO994527A patent/NO994527L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EE9900414A (et) | 2000-04-17 |
CN1251105A (zh) | 2000-04-19 |
KR20000076282A (ko) | 2000-12-26 |
BR9808346A (pt) | 2000-05-23 |
HUP0002335A3 (en) | 2002-07-29 |
IL131254A0 (en) | 2001-01-28 |
FR2761072A1 (fr) | 1998-09-25 |
JP2001518099A (ja) | 2001-10-09 |
FR2761072B1 (fr) | 1999-04-23 |
NZ337566A (en) | 2000-09-29 |
CO4940417A1 (es) | 2000-07-24 |
ZA982365B (en) | 1998-09-23 |
AR012097A1 (es) | 2000-09-27 |
NO994527L (no) | 1999-11-18 |
US6143761A (en) | 2000-11-07 |
CA2282320A1 (en) | 1998-10-01 |
WO1998042713A1 (fr) | 1998-10-01 |
HUP0002335A2 (hu) | 2001-05-28 |
AU6924298A (en) | 1998-10-20 |
PL335759A1 (en) | 2000-05-22 |
TR199902115T2 (xx) | 2000-01-21 |
BG103684A (en) | 2000-06-30 |
EP0971929A1 (fr) | 2000-01-19 |
NO994527D0 (no) | 1999-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107438606B (zh) | [9,10-二甲氧基-3-(2-甲基丙基)-1h,2h,3h,4h,6h,7h,11bh-吡啶并-[2,1-a]异喹啉-2-基]甲醇及与其相关的化合物、组合物和方法 | |
AU2001266559B2 (en) | Diazabicyclic central nervous system active agents | |
CA2372063C (en) | Pyridopyranoazepine derivatives, their preparation and their therapeutic application | |
US7897595B2 (en) | Pyridoazepine derivatives | |
JP2012529529A (ja) | ヒスタミンh3インバースアゴニスト及びアンタゴニスト、並びにその使用方法 | |
CA2354606C (en) | Azabicycloalkane derivatives and therapeutic uses thereof | |
SK127699A3 (en) | 2,3-dihydrofuro[3,2-b]pyridin, preparation and application thereof in therapy | |
CN112457305A (zh) | 含三环结构的芳香杂环化合物,及其制备方法和应用 | |
EP0596897B1 (en) | Hydroisoquinoline derivatives | |
EP2496579B1 (en) | 1-substituted 2-azabicyclo[3.1.1]heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders | |
WO2005007655A1 (en) | Nicotine addiction reducing heteroaryl fused azapolycyclic compounds | |
IE903616A1 (en) | Neuroprotectant Agents | |
JP2891543B2 (ja) | ナフチリドンカルボン酸塩を製造するための方法および中間体 | |
GB1563745A (en) | Methanobenzazocine derivatives and process for preparing the same | |
KR20110009064A (ko) | 신규의 크로멘 화합물, 이들의 제조 방법 및 이를 함유한 약제학적 조성물 | |
SK212000A3 (en) | 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy | |
SK17912000A3 (sk) | 2-aminopyridny obsahujce kondenzovan cyklick substituenty ako inhibtory syntzy oxidu dusnatho | |
CZ328599A3 (cs) | Deriváty 2,3-dihydrofuro[3,2-b]pyridinu, způsob jejich přípravy a jejich použití jako léčiv | |
MXPA99008537A (en) | 2,3-DIHYDROFURO[3,2-b | |
JP2719063B2 (ja) | 置換3−アミノキヌクリジンp物質拮抗剤 | |
CA2563575C (en) | Enantiomerically pure hexahydropyrrolocyclopentapyridine derivatives | |
JPH01250353A (ja) | 9−アシルアミノ−テトラヒドロアクリジン誘導体及び該誘導体を有効成分とする記憶障害改善剤 | |
CN117736205A (zh) | 作为mc4r拮抗剂的稠环化合物、药物组合物及其在医药上的应用 | |
CZ200030A3 (cs) | Deriváty 6-pyrrolidin-2-ylpyrindinů, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje | |
NZ299049A (en) | Thienyl-piperidine-substituted 8-azabicyclo[3.2.1] octane derivatives, medicaments |